Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email
Photo of Dr. Vignesh Gunasekharan, Ph.D.

Vignesh Gunasekharan, Ph.D.

240-276-5814 |

Dr. Vignesh Gunasekharan has expertise in viral oncology, cancer target discovery, and the development of preventive and therapeutic cancer drugs. He manages a portfolio of grants elucidating the mechanisms underlying tumor viruses and identifying strategies to intercept cancer initiation, development, and progression.

 

Background

Prior to joining DCB in 2026, Dr. Gunasekharan served as the Director of Operations for the PREVENT Cancer Preclinical Drug Development Program (PREVENT) within the NCI Division of Cancer Prevention (DCP). He also served as a Program Director and Project Officer for the Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT). Additionally, he contributed to several NCI initiatives, including the Innovative Molecular Analysis Technologies (IMAT) Program and the Small Business Innovation Research (SBIR) Program.

 

Education

  • Ph.D., Cancer Biology, Queen’s University, Belfast, U.K.
Email